[HTML][HTML] An update on clinical trials and potential therapeutic strategies in T-cell acute lymphoblastic leukemia
J Patel, X Gao, H Wang - International Journal of Molecular Sciences, 2023 - mdpi.com
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia
J Patel, X Gao, H Wang - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
J Patel, X Gao, H Wang - International Journal of Molecular …, 2023 - search.ebscohost.com
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
[HTML][HTML] An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia
J Patel, X Gao, H Wang - International Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia
J Patel, X Gao, H Wang - International Journal of Molecular …, 2023 - europepmc.org
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
J Patel, X Gao, H Wang - International Journal of Molecular …, 2023 - europepmc.org
Current therapies for T-cell acute leukemia are based on risk stratification and have greatly
improved the survival rate for patients, but mortality rates remain high owing to relapsed …
improved the survival rate for patients, but mortality rates remain high owing to relapsed …